Medical treatment of biliary tract cancer: from peri-operative to palliative care, what's on?

被引：0
作者：
Boucher, E. [1 ]
机构：
[1] Ctr Eugene Marquis, CS 44229, F-35042 Rennes, France
来源：
ONCOLOGIE | 2012年 / 14卷 / 03期
关键词：
Biliary tract cancer; Medical treatment; Perioperative treatment; Palliative therapy; Chemotherapy; Radiotherapy; PHASE-II TRIAL; UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA; QUALITY-OF-LIFE; GALLBLADDER CANCER; HILAR CHOLANGIOCARCINOMA; BILE-DUCT; LIVER-TRANSPLANTATION; NEOADJUVANT CHEMORADIATION; ADJUVANT CHEMOTHERAPY; PHOTODYNAMIC THERAPY;
D O I：
10.1007/s10269-012-2135-z
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Biliary tract cancers (BTCs) encompass different cancers: intrahepatic, Katskin tumor, gallbladder, and main bile duct cancer. Surgical management of these cancers is difficult and most patients with BTC are likely to present with an unresectable or metastatic disease. Although standard systemic chemotherapy approaches are emerging, the prognosis remains poor. Development of adaptive therapeutic strategies is ongoing, as a better knowledge about these tumors is emerging.
引用
收藏
页码：150 / 157
页数：8
相关论文
共 39 条
[11]   A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer [J].
Mattiucci, Gian Carlo ;
Autorino, Rosa ;
Tringali, Andrea ;
Perri, Vincenzo ;
Balducci, Mario ;
Deodato, Francesco ;
Gambacorta, Maria Antonietta ;
Mantini, Giovanna ;
Tagliaferri, Luca ;
Mutignani, Massimiliano ;
Morganti, Alessio. Giuseppe .
BRACHYTHERAPY, 2015, 14 (03) :401-404
[12]   Gemcitabine and S-1 versus gemcitabine and cisplatin treatment in patients with advanced biliary tract cancer: a multicenter retrospective study [J].
Naminatsu Takahara ;
Hiroyuki Isayama ;
Yousuke Nakai ;
Takashi Sasaki ;
Kazunaga Ishigaki ;
Kei Saito ;
Dai Akiyama ;
Rie Uchino ;
Suguru Mizuno ;
Hiroshi Yagioka ;
Hirofumi Kogure ;
Osamu Togawa ;
Saburo Matsubara ;
Yukiko Ito ;
Nobuo Toda ;
Minoru Tada ;
Kazuhiko Koike .
Investigational New Drugs, 2017, 35 :269-276
[13]   Gemcitabine and S-1 versus gemcitabine and cisplatin treatment in patients with advanced biliary tract cancer: a multicenter retrospective study [J].
Takahara, Naminatsu ;
Isayama, Hiroyuki ;
Nakai, Yousuke ;
Sasaki, Takashi ;
Ishigaki, Kazunaga ;
Saito, Kei ;
Akiyama, Dai ;
Uchino, Rie ;
Mizuno, Suguru ;
Yagioka, Hiroshi ;
Kogure, Hirofumi ;
Togawa, Osamu ;
Matsubara, Saburo ;
Ito, Yukiko ;
Toda, Nobuo ;
Tada, Minoru ;
Koike, Kazuhiko .
INVESTIGATIONAL NEW DRUGS, 2017, 35 (03) :269-276
[14]   What Happens Now? Psychosocial Care for Cancer Survivors After Medical Treatment Completion [J].
Stanton, Annette L. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (11) :1215-1220
[15]   S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study [J].
Furuse, Junji ;
Okusaka, Takuji ;
Boku, Narikazu ;
Ohkawa, Shinichi ;
Sawaki, Akira ;
Masumoto, Toshikazu ;
Funakoshi, Akihiro .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (05) :849-855
[16]   S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study [J].
Junji Furuse ;
Takuji Okusaka ;
Narikazu Boku ;
Shinichi Ohkawa ;
Akira Sawaki ;
Toshikazu Masumoto ;
Akihiro Funakoshi .
Cancer Chemotherapy and Pharmacology, 2008, 62 :849-855
[17]   A Retrospective Study of S-1 Monotherapy as Second-line Treatment for Patients with Advanced Biliary Tract Cancer [J].
Kobayashi, Satoshi ;
Ueno, Makoto ;
Ohkawa, Shinichi ;
Andou, Tomoko ;
Kameda, Ryo ;
Yamamoto, Naoto ;
Morinaga, Soichiro .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (09) :800-806
[18]   Treatment options for biliary tract cancer: unmet needs, new targets and opportunities from both physicians' and patients' perspectives [J].
Shroff, Rachna T. ;
Bachini, Melinda .
FUTURE ONCOLOGY, 2024, 20 (20) :1435-1450
[19]   Comparative Cost-Effectiveness of Gemcitabine and Cisplatin in Combination with S-1, Durvalumab, or Pembrolizumab as First-Line Triple Treatment for Advanced Biliary Tract Cancer [J].
Kashiwa, Munenobu ;
Maeda, Hiroyuki .
JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (04) :1569-1580
[20]   Assessing response to treatment of bone metastases from breast cancer: what should be the standard of care? [J].
Woolf, D. K. ;
Padhani, A. R. ;
Makris, A. .
ANNALS OF ONCOLOGY, 2015, 26 (06) :1048-1057
1234